NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on cMYC Study
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-36
Protocol B-37
Protocol B-39
Protocol B-40
Protocol B-41
Protocol B-42
Protocol C-10
Protocol R-04
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
BreastCancerPrevention.com
Bibliography of Publications
Related Web Sites
About the NSABP Web Site
Helper Applications
Links to Major Search Engines
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol B-13
A Protocol To Assess Sequential Methotrexate → Fluorouracil In Patients With Primary Breast Cancer And Negative Axillary Nodes Whose Tumors Are Negative For Estrogen Receptors
Specific Aims
The primary objective of this study is to determine whether the sequential combination M→F is more effective than no treatment with respect to disease-free survival and survival in patients whose tumors are estrogen-receptor-negative.
In addition, this study, in conjunction with Protocol B-14, will permit evaluation of treatment failure and survival in untreated patients relative to their ER level.
